Standard BioTools

Standard BioTools R&D per Employee

The R&D Spending per Employee of Standard BioTools (LAB) as of Sep 24, 2026 is 66,804.63 USD. In the previous year, R&D Spending per Employee was 160,439.59 USD — a change of -58.36% (lower).

R&D per Employee

66,804.63USD

YoY

-58.36%

Last updated:

R&D Spending per Employee of Standard BioTools is 2026 66,804.63 USD. R&D Spending per Employee of Standard BioTools was 2025 160,439.59 USD. It decreases by -58.36% lower compared to the previous year.

The Standard BioTools R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
77,197.94 USD
Jan 1, 2019
81,336.76 USD
Jan 1, 2020
93,730.08 USD
Jan 1, 2021
97,542.42 USD
Jan 1, 2022
96,097.69 USD
Jan 1, 2023
66,704.37 USD
Jan 1, 2024
160,439.59 USD
Jan 1, 2025
66,804.63 USD
The Standard BioTools R&D per Employee history
YEARR&D per EmployeeYoY
66,804.63USD-58.36%
160,439.59USD+140.52%
66,704.37USD-30.59%
96,097.69USD-1.48%
97,542.42USD+4.07%
93,730.08USD+15.24%
81,336.76USD+5.36%
77,197.94USD-2.58%
79,244.22USD-19.76%
98,753.21USD-2.16%
100,935.73USD-9.58%
111,627.25USD—
Access this data via the Eulerpool API

Standard BioTools Stock analysis

What does Standard BioTools do? Fluidigm Corp is a biotechnology company specializing in innovative devices and solutions for DNA sequencing. The company was founded in 1999 in San Francisco and is currently headquartered in South San Francisco. It developed the Microfluidic Technology-Sensor, which allows for handling tiny amounts of fluids in a small space. This technology has enabled researchers to analyze complex samples and collect data with high accuracy. The company operates in two main segments: Analytical Instruments and Sample Preparation. In the Analytical Instruments segment, Fluidigm offers various devices suitable for DNA sequencing, including the Juno, C1, and Biomark platforms. It also provides a wide range of consumables to facilitate sample preparation. The Sample Preparation segment offers products and services to prepare and process samples for analysis, including microfluidic technology chips and modules, single-cell sequencing systems, and products for next-generation sequencing. Fluidigm serves customers in various industries, such as genomics research, cancer research, and medical fields, with a strong presence in North America, Europe, and Asia. The company is known for its continuous investment in research and development, as well as its innovative technologies and patents. Overall, Fluidigm's Microfluidic technology platform allows researchers to collect data in a small space with high accuracy. With a diversified portfolio of products and services, the company is well-positioned to continue growing and expanding its market presence in the coming years. Standard BioTools is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Standard BioTools stock

R&D Spending per Employee of Standard BioTools is 66,804.63 USD in 2026.

R&D Spending per Employee of Standard BioTools changed from 160,439.59 USD to 66,804.63 USD, representing a -58.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Standard BioTools since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Standard BioTools historically and in real time.

Access this data via the Eulerpool API

Workforce — Standard BioTools

All Key Metrics — Standard BioTools